What is the Catheter Precision, Inc. stock price forecast?

Catheter Precision, Inc. is currently trading at $1.21. View real-time AI analysis on Alpha Lenz.

What is Catheter Precision, Inc. insider trading activity?

View the latest insider trading data for Catheter Precision, Inc. on Alpha Lenz.

What is Catheter Precision, Inc.'s P/E ratio?

Catheter Precision, Inc.'s P/E ratio is -0.0.

Catheter Precision, Inc.

NYSE · VTAK

$1.21

Ask about Catheter Precision, Inc.'s future dividend policy...

Alpha Chat Insight

“Catheter Precision, Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -101.0%. 3Y revenue CAGR of 167.3% highlights clear growth momentum.”

Ask for details →

Company Overview

Catheter Precision, Inc. is a dynamic player in the medical technology sector, specializing in the development and commercialization of advanced catheters and related technologies. The company focuses on providing innovative solutions for electrophysiology, a branch of cardiology that examines and treats arrhythmias. Their products are designed to support physicians in diagnosing and treating heart rhythm disorders with precision and efficacy. Notable features of Catheter Precision’s offerings include cutting-edge technology that enhances the accuracy of cardiac interventions and improves patient outcomes. As part of the broader healthcare sector, the company contributes to advancing medical treatments and has a significant impact on the quality of care provided to patients with cardiac issues. By continually innovating and integrating state-of-the-art technologies, Catheter Precision plays a crucial role in the electrophysiology market, offering tools that empower healthcare professionals to deliver superior cardiac care.

CEOMr. David A. Jenkins

Websitehttps://www.catheterprecision.com

SectorHealthcare

IndustryMedical Devices

Employees22

Company Statistics

FY 2024

Profile

$207.84KMarket Cap

$420.00KRevenue

0.00Shares Out

22Employees

Margins

90.00%Gross

-2690.95%EBITDA

-2676.90%Operating

-3214.76%Pre-Tax

-3962.62%Net

Valuation

-0.01P/E

0.02P/B

0.49EV/Sales

0.08EV/EBITDA

-0.02P/FCF

Growth (CAGR)

167.27%Rev 3Yr

-43.35%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-56.89%ROA

-101.02%ROE

-45.84%ROIC

Financial Health

$2.87MCash & Cash Equivalents

$13.14MNet Debt

136.20%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Catheter Precision, Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -101.0%. 3Y revenue CAGR of 167.3% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Catheter Precision, Inc. (ticker: VTAK) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 22 employees. Market cap is $207,838.

The current price is $1.21 with a P/E ratio of -0.01x and P/B of 0.02x.

ROE is -101.02% and operating margin is -2676.90%. Annual revenue is $420,000.